Literature DB >> 22788735

Central serous chorioretinopathy: a review of epidemiology and pathophysiology.

Gerald Liew1, Godfrey Quin, Mark Gillies, Samantha Fraser-Bell.   

Abstract

Central serous chorioretinopathy (CSCR) is a common retinal cause of vision loss. This review surveys the epidemiology, risk factors, clinical presentation, natural history and pathophysiology of CSCR. Studies suggest an annual incidence rate of 10 per 100 000 in men, with CSCR occurring six times more commonly in men compared with women. Most acute CSCR cases resolve spontaneously within 2-3 months. Prognosis is highly dependent on presenting visual acuity; patients with initial visual acuities of 6/6 remain at that level, while patients with initial visual acuities of less than 6/9 recover on average two to three Snellen lines over the next few years. The main risk factors for CSCR are systemic corticosteroid use, type A personality, pregnancy and endogenous Cushing's syndrome. The pathophysiology of CSCR remains obscure, although disorders in both the choroidal circulation and retinal pigment epithelium are implicated.
© 2012 The Authors. Clinical and Experimental Ophthalmology © 2012 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Mesh:

Year:  2012        PMID: 22788735     DOI: 10.1111/j.1442-9071.2012.02848.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  107 in total

1.  Combined 60° Wide-Field Choroidal Thickness Maps and High-Definition En Face Vasculature Visualization Using Swept-Source Megahertz OCT at 1050 nm.

Authors:  Kathrin J Mohler; Wolfgang Draxinger; Thomas Klein; Jan Philip Kolb; Wolfgang Wieser; Christos Haritoglou; Anselm Kampik; James G Fujimoto; Aljoscha S Neubauer; Robert Huber; Armin Wolf
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-10       Impact factor: 4.799

2.  Effect of a topical nonsteroidal anti-inflammatory agent (0.1 % pranoprofen) on acute central serous chorioretinopathy.

Authors:  Seoung Hyun An; Yoon Hyung Kwon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-11-09       Impact factor: 3.117

3.  Response of central serous chorioretinopathy evaluated by multimodal retinal imaging.

Authors:  R Sacconi; G Baldin; A Carnevali; L Querques; A Rabiolo; G Marchini; F Bandello; G Querques
Journal:  Eye (Lond)       Date:  2018-01-05       Impact factor: 3.775

4.  Measurement of choroidal thickness and macular thickness during and after pregnancy.

Authors:  Döndü Melek Ulusoy; Necati Duru; Mustafa Ataş; Hasan Altınkaynak; Zeynep Duru; Gökhan Açmaz
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

5.  Retinal pigment epithelium apertures as a late complication of longstanding serous pigment epithelium detachments in chronic central serous chorioretinopathy.

Authors:  Claudio Iovino; Jay Chhablani; Deepika C Parameswarappa; Marco Pellegrini; Giuseppe Giannaccare; Enrico Peiretti
Journal:  Eye (Lond)       Date:  2019-07-02       Impact factor: 3.775

6.  Response to 'Comment on 'Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy''.

Authors:  P Scholz; L Altay; S Fauser
Journal:  Eye (Lond)       Date:  2016-11-04       Impact factor: 3.775

7.  Comment on 'Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy'.

Authors:  E H C van Dijk; C J F Boon
Journal:  Eye (Lond)       Date:  2016-11-04       Impact factor: 3.775

8.  En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy.

Authors:  Daniela Ferrara; Kathrin J Mohler; Nadia Waheed; Mehreen Adhi; Jonathan J Liu; Ireneusz Grulkowski; Martin F Kraus; Caroline Baumal; Joachim Hornegger; James G Fujimoto; Jay S Duker
Journal:  Ophthalmology       Date:  2013-11-26       Impact factor: 12.079

9.  Comparison of two mineralcorticosteroids receptor antagonists for the treatment of central serous chorioretinopathy.

Authors:  Francesco Pichi; Paola Carrai; Antonio Ciardella; Francine Behar-Cohen; Paolo Nucci
Journal:  Int Ophthalmol       Date:  2016-10-18       Impact factor: 2.031

Review 10.  Retinal Diseases that Can Masquerade as Neurological Causes of Vision Loss.

Authors:  Tanyatuth Padungkiatsagul; Loh-Shan Leung; Heather E Moss
Journal:  Curr Neurol Neurosci Rep       Date:  2020-09-15       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.